Singapore markets closed
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
4,997.97 -73.66 (-1.45%) Dow
37,767.65 -693.27 (-1.80%) Nasdaq
15,422.78 -289.97 (-1.85%) Bitcoin USD
63,264.34 -1,711.20 (-2.63%) CMC Crypto 200
1,374.91 -7.66 (-0.55%)
BioNexus Gene Lab Corp. (BGLC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:46AM EDT. Market open.
| Previous close | 0.5950 |
| Open | 0.5800 |
| Bid | 0.4269 x 200 |
| Ask | 0.7927 x 200 |
| Day's range | 0.5800 - 0.6250 |
| 52-week range | 0.0800 - 9.4900 |
| Volume | |
| Avg. volume | 1,576,943 |
| Market cap | 10.776M |
| Beta (5Y monthly) | 1.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
KUALA LUMPUR, Malaysia, April 19, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ: BGLC), a global leader in genomic diagnostics and healthcare technology, announces a strategic investment by its wholly owned subsidiary, MRNA Scientific Sdn Bhd, in Ascension Innovation Sdn Bhd (AISB), a privately held Malaysian company. This investment underscores BGLC’s commitment to advancing healthcare solutions through cutting-edge AI and predictive analytics. Background: MRNA Scientific Sdn B
© 2024 Yahoo. All rights reserved.